89.17
price down icon2.28%   -2.08
after-market アフターアワーズ: 88.75 -0.42 -0.47%
loading
前日終値:
$91.25
開ける:
$91.32
24時間の取引高:
11.89M
Relative Volume:
0.94
時価総額:
$155.32B
収益:
$45.13B
当期純損益:
$6.28B
株価収益率:
24.84
EPS:
3.5895
ネットキャッシュフロー:
$7.38B
1週間 パフォーマンス:
+2.51%
1か月 パフォーマンス:
+5.75%
6か月 パフォーマンス:
-27.24%
1年 パフォーマンス:
-33.52%
1日の値動き範囲:
Value
$88.69
$91.32
1週間の範囲:
Value
$88.69
$92.73
52週間の値動き範囲:
Value
$81.97
$139.06

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1101)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
115,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2026-07-16
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

Compare ABT vs SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ABT icon
ABT
Abbott Laboratories
89.17 158.94B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
308.84 120.38B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
80.25 105.25B 36.36B 4.84B 5.43B 3.7212
BSX icon
BSX
Boston Scientific Corp
48.34 72.77B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
85.98 50.41B 6.30B 1.07B 1.09B 1.8406

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-22 ダウングレード Daiwa Securities Outperform → Neutral
2025-10-10 開始されました The Benchmark Company Buy
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
06:13 AM

Abbott Diabetes And Cancer Milestones Contrast With Prolonged Share Price Weakness - Yahoo Finance

06:13 AM
pulisher
04:04 AM

Abbott office in Easton part of multi-state portfolio sale - The Business Journals

04:04 AM
pulisher
02:01 AM

Abbott Laboratories Hit With Lawsuit Over Healthcare Plan Costs - Bloomberg Law News

02:01 AM
pulisher
01:49 AM

Abbott Defeats Account Manager’s Sexualized Workplace Claim - Bloomberg Law News

01:49 AM
pulisher
09:21 AM

Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story - Yahoo Finance

09:21 AM
pulisher
09:00 AM

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

09:00 AM
pulisher
06:29 AM

BSX, MDT Top Abbott Laboratories Stock on Price & Potential - Trefis

06:29 AM
pulisher
04:10 AM

Abbott Laboratories: A Better Than 5 Years AgoBut Still Not A Buy - Seeking Alpha

04:10 AM
pulisher
Jun 09, 2026

3 Large Cap Defensive Dividend Stocks With Underestimated Payout Power - simplywall.st

Jun 09, 2026
pulisher
Jun 09, 2026

Abbott (ABT) Secures CE Mark for World’s First Dual Glucose‑Ketone Sensing Technology for Diabetes - Insider Monkey

Jun 09, 2026
pulisher
Jun 09, 2026

Abbott Laboratories stock (US0028241000): New filing, modest gain, and valuation focus - AD HOC NEWS

Jun 09, 2026
pulisher
Jun 09, 2026

Abbott Laboratories stock (US0028241000): analysts stay positive as new diabetes data and steady gai - AD HOC NEWS

Jun 09, 2026
pulisher
Jun 09, 2026

Abbott Laboratories price gives in to negative pressureForecast today09-06-2026 - Economies.com

Jun 09, 2026
pulisher
Jun 09, 2026

ABT DCF Analysis: Intrinsic Value $93 vs Price $90 - GuruFocus

Jun 09, 2026
pulisher
Jun 09, 2026

Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $109 - Moomoo

Jun 09, 2026
pulisher
Jun 09, 2026

Richard W. Allen Sells Shares in Abbott Laboratories, Ameriprise Financial and More - Investing.com Nigeria

Jun 09, 2026
pulisher
Jun 08, 2026

Similac baby formula maker sued by Allegheny County parents over infant’s 2011 death - TribLIVE.com

Jun 08, 2026
pulisher
Jun 08, 2026

Abbott Laboratories, maker of Similac baby formula, sued by Allegheny County parents over infant’s 2011 death - TribLIVE.com

Jun 08, 2026
pulisher
Jun 08, 2026

Governor Abbott, Secretary Rollins Update Texans On Screwworm Response At Kerrville Lab - Office of the Texas Governor (.gov)

Jun 08, 2026
pulisher
Jun 08, 2026

Abbott's Healthy Food Rx Program Shows Promising Results for Dia - GuruFocus

Jun 08, 2026
pulisher
Jun 08, 2026

Is It Time To Revisit Abbott Laboratories (ABT) After This Year’s Share Price Slump? - Yahoo Finance

Jun 08, 2026
pulisher
Jun 08, 2026

Can Beyond Meat's Pivot to Protein Drinks Change the Investment Thesis? - The Motley Fool

Jun 08, 2026
pulisher
Jun 08, 2026

Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock - Insider Monkey

Jun 08, 2026
pulisher
Jun 08, 2026

LIVE: Abbott activates emergency center for screwworm response, USDA says 2 more Texas cases - KLBK

Jun 08, 2026
pulisher
Jun 08, 2026

BofA Securities Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $120 - 富途牛牛

Jun 08, 2026
pulisher
Jun 08, 2026

Abbott activates emergency center for screwworm response, USDA says 2 more Texas cases - KXAN Austin

Jun 08, 2026
pulisher
Jun 08, 2026

Food boxes and coaches tied to better diabetes health, less food insecurity - Stock Titan

Jun 08, 2026
pulisher
Jun 08, 2026

Abbott Laboratories (ABT) Up 6.4% Following European CE Mark Approval of Dual Glucose-Ketone Sensors - Meyka

Jun 08, 2026
pulisher
Jun 08, 2026

Abbott Buy Rating Reaffirmed as Analyst Sees Accelerating 2027 Earnings; $120 Price Target Maintained on Libre Duo Growth Potential - TipRanks

Jun 08, 2026
pulisher
Jun 08, 2026

Abbott Laboratories (ABT) Investor Outlook: Harnessing A 28.79% Potential Upside - DirectorsTalk Interviews

Jun 08, 2026
pulisher
Jun 07, 2026

Abbott (ABT) Highlights Dangers of Diabetic Ketoacidosis in New Research Findings - GuruFocus

Jun 07, 2026
pulisher
Jun 07, 2026

Abbott Laboratories (ABT) Is Up 6.4% After European Approval of Dual Glucose‑Ketone Sensors - simplywall.st

Jun 07, 2026
pulisher
Jun 06, 2026

Abbott studies reinforce DKA opportunity following dual sensor milestone - Drug Delivery Business

Jun 06, 2026
pulisher
Jun 06, 2026

Abbott reports rising DKA hospitalizations among diabetics - Investing.com

Jun 06, 2026
pulisher
Jun 06, 2026

Kids’ diabetes hospital stays now mostly from ketoacidosis, Abbott finds - Stock Titan

Jun 06, 2026
pulisher
Jun 06, 2026

Abbott Laboratories slammed on its post-Exact Sciences guidance - MSN

Jun 06, 2026
pulisher
Jun 06, 2026

ABT Stock Quote Price and Forecast - CNN

Jun 06, 2026
pulisher
Jun 05, 2026

Abbott Says Timing Mismatch Lets $8B Gain Go Untaxed - Law360

Jun 05, 2026
pulisher
Jun 05, 2026

What is Abbott Tokenized Stock (Ondo)(ABTON) Coin? A comprehensive guide you shouldn’t miss - WEEX

Jun 05, 2026
pulisher
Jun 05, 2026

A Grandma Bought PediaSure To Help Her Grandson Grow — Now, Abbott Is In Federal Court - Benzinga

Jun 05, 2026
pulisher
Jun 05, 2026

Abbott Laboratories stock is getting decimated, but the smart money senses opportunity - MSN

Jun 05, 2026
pulisher
Jun 04, 2026

Better medical device stock right now: Abbott Laboratories vs. Dexcom - MSN

Jun 04, 2026
pulisher
Jun 04, 2026

Is It Too Late to Buy Abbott Laboratories (ABT) After 4.4% Rally? GF Value Says Undervalued - GuruFocus

Jun 04, 2026
pulisher
Jun 04, 2026

Judge Questions Fees In Abbott Investors' $40M Formula Deal - Law360

Jun 04, 2026
pulisher
Jun 04, 2026

Abbott Can’t Drop PediaSure Children’s Growth Deception Suit - Bloomberg Law News

Jun 04, 2026
pulisher
Jun 04, 2026

Abbott Labs must face lawsuit over PediaSure children's growth claims - Reuters

Jun 04, 2026
pulisher
Jun 04, 2026

Abbott Labs must face lawsuit over PediaSure children’s growth claims - The Mighty 790 KFGO

Jun 04, 2026
pulisher
Jun 04, 2026

Abbott Laboratories Stock (ABT) Closed Up by 4.18% on Jun 4: Drivers Behind the Movement - TradingKey

Jun 04, 2026
pulisher
Jun 04, 2026

Abbott Laboratories stock (US0028241000): shares advance on strong US trading - AD HOC NEWS

Jun 04, 2026
pulisher
Jun 04, 2026

[Latest] Non-Invasive Blood Glucose Monitoring Devices Market Size to Hit USD 340.49 Million with a Promising CAGR of 25.60% by 2034 - GlobeNewswire Inc.

Jun 04, 2026
pulisher
Jun 04, 2026

Abbott Laboratories stock gains as Norges Bank acquires new institutional position - Traders Union

Jun 04, 2026

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
SYK SYK
$308.84
price down icon 1.65%
MDT MDT
$80.25
price down icon 2.11%
BSX BSX
$48.34
price down icon 1.27%
EW EW
$85.98
price down icon 1.78%
$63.76
price down icon 3.41%
大文字化:     |  ボリューム (24 時間):